News

Panelists discussed a variety of topics including: drug trials and updates on the remdesivir and hydroxychloroquine studies, reports of possible vaccine progress, treating COVID in the ICU, public health policy, research on how the pandemic is progressing, safe re-openings, successful interventions and what still needs to be done.

The need for trusted knowledge and expertise is most valuable during a time of crisis. In response to the coronavirus, experts across Duke University and Duke Health have been critical in informing policymakers at the local, state, and national level. Scholars, doctors, and Duke administrators collaborate with policymakers every day, but have been increasingly engaged on public policy decisions as our nation responds to the unprecedented COVID-19 pandemic. 

When infected with SARS-CoV-2, why do some people—such as smokers and older adults— have extreme respiratory and cardiovascular distress while others have no symptoms at all?

We are so proud of our DHVI and Duke RBL researchers and staff, who are working tirelessly to ensure the safety our healthcare workers and develop a vaccine and therapeutic countermeasures against COVID-19. In this video, Dr. Greg Sempowski, Director of the Duke Regional Biocontainment Laboratory (RBL), talks about the efforts of this extraordinary team and the in-house resources at Duke.

Facing a critical shortage of N95 face masks that block the coronavirus, Duke Health research and clinical teams have confirmed a way to use existing vaporized hydrogen peroxide methods to decontaminate the masks so they can be reused.

Although most research laboratories at Duke University are shuttered to prevent future transmission of the Covid-19 coronavirus, one of the few to remain open houses a powerful machine that Duke researchers think will be instrumental in developing a vaccine for the virus.

Everything Duke experts have learned over the years about the spread of new diseases, the biology of viruses, and the techniques of developing treatments and vaccines is now being applied to the new coronavirus, SARS-CoV-2, and the illness it causes, COVID-19.

Duke University Hospital has joined the first national study to test a potential therapy for COVID-19, giving hospitalized adult patients with significant symptoms an option to participate.

A Duke University professor of medicine and global health has been studying emerging infections for his entire career but has yet to see anything capture the attention of society quite like this.

Officials at Duke, along with health officials worldwide, are monitoring an outbreak of pneumonia caused by a novel (new) coronavirus that originated in late 2019. We are not aware of any 2019 novel coronavirus (COVID-19) cases at any Duke campus or facility. We are providing this information to raise awareness and inform the Duke community.